retatrutide phase 2 trial type 2 diabetes triple agonist glp-1 gip glucagon obesity Retatrutide, a GIP, and receptor retatrutide weight loss phase 2

Ethics statement The studies involving humans were approved by the Regional Committee for Medical and Health Research Ethics Southeast in Norway (REK2015-1621)

Additionally, BPC-157 has been shown to regulate inflammatory responses by reducing pro-inflammatory cytokines and stimulating the release of growth factors vital for healing

Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U, Conzen P, Becker BF

GHK-Cu and Infection-Related Readouts in Wound Contexts Mouse and clinical datasets point to a possible reduction in inflammatory proteases (for example, MMP-2/9) and cytokines (such as TNF-) in wounds exposed to GHK-Cu, aligning with lower observed infection rates in comparative ulcer care cohorts